Skip to main navigation Skip to search Skip to main content

A Phase 2, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Assess the Safety, Efficacy, and Tolerability of ARGX-117 in Improving Allograft Function in Recipients of a Deceased Donor Renal Allograft at Risk for Delayed

Project: Research

Project Details

StatusActive
Effective start/end date07/29/24 → 05/1/27

Funding

  • CTI Clinical Trial Services Incorporated: $68,587.70